ESTABLISHMENT LABS HLDGS

Research ESTABLISHMENT LABS HLDGS (3E0) on Bullrun: market cap EUR 1.85B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is EUR 1.85B.

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025USD 211.08M-USD 51.06M-USD 57.61M69.3%n/aUSD 75.57MUSD 264.47MUSD 23.55M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-24EUR 1.85Bn/an/a0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 EUR.

About ESTABLISHMENT LABS HLDGS

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for breast aesthetic and reconstructive plastic surgeries in Europe, the Middle East, Africa, Latin America, Asia, and the United States. The company offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides breast tissue expanders. The company sells products to physicians, hospitals, and clinics through distributors and its direct sales force. Establishment Labs Holdings Inc.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is ESTABLISHMENT LABS HLDGS's market cap?

ESTABLISHMENT LABS HLDGS's market capitalization is EUR 1.85B.

What does ESTABLISHMENT LABS HLDGS do?

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for breast aesthetic and reconstructive plastic surgeries in Europe, the Middle East, Africa, Latin America, Asia, and the United States. The company offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides breast tissue expanders. The company sells products to physicians, hospitals, and clinics through distributors and its direct sales force. Establishment Labs Holdings Inc. was incorporated in 2004 and is based in Austin, Texas.